Sean M. Macdonald
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials.
Journal: European urology
Published: November 03, 2025
Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2024
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer.
Journal: Nature reviews. Urology
Published: June 21, 2024
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.
Journal: Science translational medicine
Published: April 05, 2023
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells.
Journal: Haematologica
Published: October 04, 2021
Using Mass Cytometry to Analyze the Tumor-Infiltrating Lymphocytes in Human Melanoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2021
Multiplex Immunohistochemistry Analysis of Melanoma Tumor-Infiltrating Lymphocytes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Journal: Nature immunology
Published: October 10, 2020
Do evolutionary constraints on thermal performance manifest at different organizational scales?
Journal: Journal of evolutionary biology
Published: August 18, 2014
Last Updated: 09/26/2026